YL3-22360-66048
1 vaccination
1 coded response
16 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 986 / WA
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-03
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-05
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-10
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-17
- 2021-04-25
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-07-03
- 2021-10-02
-
2022-04-03
Survey response — 12 months, dose 1MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Pregnancy!MedDRA releases: 2024-11 · check-in free text available
-
2022-04-03
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-05
- 2022-04-08
- 2022-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-03 | Unsuccessful |
Free text
Release 11 — 12 months, dose 1
Symptoms: Pregnancy!
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release